欧林生物: 成都欧林生物科技股份有限公司第七届董事会独立董事专门会议2025年第二次会议决议

Group 1 - The independent board meeting of Chengdu Olin Biotechnology Co., Ltd. was held on August 29, 2025, with all three independent directors present, confirming the legality and validity of the meeting [1][2] - The meeting unanimously approved the proposal to terminate the simplified procedure for issuing A-shares to specific targets and to withdraw the application documents, indicating a prudent decision based on the company's actual situation [1] - The independent directors concluded that this decision would not adversely affect the company's production, operations, or business development, nor would it harm the interests of the company and all shareholders [1]